Abstract:Molecular controllers of the number and function of tissue stem cells may share common regulatory pathways for the nuclear reprogramming of somatic cells to become induced Pluripotent Stem Cells (iPSCs). If this hypothesis is true, testing the ability of longevity-promoting chemicals to improve reprogramming efficiency may provide a proof-of-concept validation tool for pivotal housekeeping pathways that limit the numerical and/or functional decline of adult stem cells. Reprogramming is a slow, stochastic process due to the complex and apparently unrelated cellular processes that are involved. First, forced expression of the Yamanaka cocktail of stemness factors, OSKM, is a stressful process that activates apoptosis and cellular senescence, which are the two primary barriers to cancer development and somatic reprogramming. Second, the a priori energetic infrastructure of somatic cells appears to be a crucial stochastic feature for optimal successful routing to pluripotency. If longevity-promoting compounds can ablate the drivers and effectors of cellular senescence while concurrently enhancing a bioenergetic shift from somatic oxidative mitochondria toward an alternative ATP-generating glycolytic metabotype, they could maximize the efficiency of somatic reprogramming to pluripotency. Support for this hypothesis is evidenced by recent findings that well-characterized mTOR inhibitors and autophagy activators (e.g., PP242, rapamycin and resveratrol) notably improve the speed and efficiency of iPSC generation. This article reviews the existing research evidence that the most established mTOR inhibitors can notably decelerate the cellular senescence that is imposed by DNA damage-like responses, which are somewhat equivalent to the responses caused by reprogramming factors. These data suggest that fine-tuning mTOR signaling can impact mitochondrial dynamics to segregate mitochondria that are destined for clearance through autophagy, which results in the loss of mitochondrial function and in the accelerated onset of the glycolytic metabolism that is required to fuel reprogramming. By critically exploring how mTOR-regulated senescence, bioenergetic infrastructure and autophagy can actively drive the reprogramming of somatic cells to pluripotency, we define a metabolic roadmap that may be helpful for designing pharmacological and behavioral interventions to prevent or retard the dysfunction/exhaustion of aging stem cell populations.

Atg5-independent Autophagy Regulates Mitochondrial Clearance and is Essential for Ipsc Reprogramming

Rapamycin and other longevity-promoting compounds enhance the generation of mouse induced pluripotent stem cells.

ATG3-dependent Autophagy Mediates Mitochondrial Homeostasis in Pluripotency Acquirement and Maintenance

Mtorc1‐pgc1 Axis Regulates Mitochondrial Remodeling During Reprogramming

BNIP3L-dependent mitophagy accounts for mitochondrial clearance during 3 factors-induced somatic cell reprogramming.

Mitochondrial metabolism transition cooperates with nuclear reprogramming during induced pluripotent stem cell generation.

Autophagy and mTORC1 regulate the stochastic phase of somatic cell reprogramming

Mitochondrial regulation in human pluripotent stem cells during reprogramming and β cell differentiation

Metabolic remodeling during somatic cell reprogramming to induced pluripotent stem cells: involvement of hypoxia-inducible factor 1

The Paf1 Complex Transcriptionally Regulates the Mitochondrial-Anchored Protein Atg32 Leading to Activation of Mitophagy.

Metabolic control of induced pluripotency

mTOR-regulated senescence and autophagy during reprogramming of somatic cells to pluripotency: A roadmap from energy metabolism to stem cell renewal and aging

Use of Inducible Atg5 Deletion and Expression Cell Lines in Study of the Pro-Survival Function of Autophagy under Starvation

Brief Report: Combined Chemical Treatment Enables Oct4-Induced Reprogramming from Mouse Embryonic Fibroblasts

A degradative to secretory autophagy switch mediates mitochondria clearance in the absence of the mATG8-conjugation machinery

Nuclear localization of mitochondrial TCA cycle enzymes modulates pluripotency via histone acetylation

BNIP3 (BCL2 Interacting Protein 3) Regulates Pluripotency by Modulating Mitochondrial Homeostasis Via Mitophagy

PINK1‐mediated mitophagy maintains pluripotency through optineurin

Autophagy and cell reprogramming.

ATG7-mediated autophagy facilitates embryonic stem cell exit from naive pluripotency and marks commitment to differentiation

mcPGK1-dependent mitochondrial import of PGK1 promotes metabolic reprogramming and self-renewal of liver TICs